bone fixation News
-
Centric Medical Announces New Release of Sterile-Packed Rogue+™ Hammertoe Correction System Implants
Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the release of the ROGUE+ Hammertoe Correction System. This sterile-packed innovative system adds to the original implant design also available, while providing internal fixation via a dual threaded construct which is ...
-
OSSIO Awarded FDA 510(k) Clearance for OSSIOfiber Compression Screw Portfolio
OSSIO, Inc., an orthopedic fixation technology company, today announced that its OSSIOfiber® Compression Screw Portfolio has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, comminuted fractures, fragments, osteotomies, arthrodesis and bone grafts of the upper extremity, fibula, knee, ankle and foot ...
By OSSIO Inc
-
Medical Microinstruments’ Symani Surgical System Saves Patient’s Arm from Amputation
CALCl, Italy, July 13, 2021- Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today that MMI's Symani® Surgical System was successfully used at Careggi University Hospital Florence by Prof. Marco Innocenti and his team in a complex, post-traumatic limb reconstruction that saved a patient's arm from ...
-
Centric Medical Announces FDA 510(K) Clearance of the Foot and Ankle Plating System
Centric Medical, a division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the FDA 510(k) clearance of the new Foot and Ankle Plating System. This clearance offers multiple surgical solutions by Centric Medical, to be used in Foot & Ankle reconstruction procedures. The Centric Medical Foot and Ankle Plating ...
-
ASTM F1541 - 02(2011) standard specification and test methods for external skeletal fixation devices
A1.4.1 The purpose of this classification is to establish a consistent terminology system by means of which these ESFD configurations can be classified. It is anticipated that a companion testing standard using this classification system will subsequently be developed. 1. Scope 1.1 This specification provides a characterization of the design and mechanical function of ...
-
OSSIO Receives Vizient Contract for Bio-Integrative Orthopedic Fixation Technology
OSSIO, Inc., an orthopedic fixation technology company, today announced that it has received a contract with Vizient, Inc., making the company’s portfolio of bio-integrative OSSIOfiber products available at negotiated pricing to health care providers in Vizient’s group purchasing organization (GPO) under a three-year contract starting March 1. OSSIO’s contract with Vizient ...
By OSSIO Inc
-
LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures
LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of Neurological Disorders and Stroke to advance the development of Tetranite®, its bone adhesive biomaterial technology, to improve cranial flap fixation procedures. The clinical use of this product is expected ...
By RevBio Inc.
-
Procyrion Names AV Edidin, Ph.D., as Senior Vice President of Development and Manufacturing
Procyrion, Inc., a clinical-stage medical device company developing the Aortix™ system, a percutaneous blood pump initially targeted for treating patients with heart failure and worsening kidney function (cardiorenal syndrome), announced the appointment of Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing. In this role, Edidin will lead and oversee product ...
-
Field Orthopaedics announces strategic alliance with Medartis Inc
The strategic alliance will see the NX Nail system from Field Orthopaedics added to Medartis’ comprehensive hand portfolio in an exclusive distribution partnership, which will extend the global distribution footprint of the product and provide growth opportunities in international markets. With an anatomically inspired head, narrow waist and cutting efficiency, the NX Nail is engineered to ...
-
World’s First “Artificial Meniscus” Available in Israel
Active Implants LLC, a company that develops orthopedic implant solutions, today announced that two patients in Israel have undergone knee surgery for the company’s NUsurface® Meniscus Implant – the first “artificial meniscus” to be marketed in the Middle East. Until now, the NUsurface Implant was only available in Israel in clinical trials. The procedures were ...
-
Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego
Active Implants, a company that develops orthopedic implant solutions, today announced that the company’s SUN (Safety Using NUsurface) trial is now underway in San Diego. Dr. Scott A. Hacker at Grossmont Orthopaedic Medical Group is the only physician in San Diego County – and the center is one of just 10 sites nationwide – participating in the SUN clinical trial to evaluate the ...
-
Acumed Acquires Exsomed to Enhance Its Portfolio of Upper Extremity Solutions
Acumed, a Colson Medical - Marmon - Berkshire Hathaway company, is excited to announce the acquisition of ExsoMed, a provider of innovative solutions for hand surgery. The addition of ExsoMed, whose products support an intramedullary approach to treating hand fractures, enhances Acumed’s comprehensive portfolio of upper extremity solutions for simple to complex injuries. Acumed, a Colson ...
-
First BioPoly Great Toe Surgery Performed in US
FORT WAYNE, IN – BioPoly LLC has announced that the first BioPoly® Great Toe surgery in the U.S. was completed on September 30, 2021. The surgery was performed by Dr. Steve Herbst of Central Indiana Orthopedics in Muncie, Indiana. “The BioPoly Great Toe implant addresses a large unmet need in the market, and we are thrilled to have it available in the U.S. now. This small implant ...
By BioPoly, LLC
-
CoNextions Inc. Announces FDA 510(k) Clearance of Coronet System, a Revolutionary Tenodesis Product
CoNextions Inc. (www.conextionsmed.com) announced today that it received a 510(k) clearance (K200028) from the U.S. Food and Drug Administration (FDA) for CoronetTM System, a tenodesis product intended for the fixation of tissue to bone and tissue to tissue. The Coronet’s novel design improves the soft tissue fixation strength of these repairs compared to conventional suture repairs. A ...
-
ASTM F2091 - 01(2012) Standard Specification for Acetabular Prostheses
This specification covers acetabular resurfacing devices used to provide a functioning articulation between the bones of the acetabulum and the femur. Acetabular prostheses included within the scope of this specification are intended for mechanical fixation between the prosthesis and host bone, by the use of bone cement ...
-
Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant
Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced that the NUsurface® Meniscus Implant has been granted a Breakthrough Device Designation from the U.S. Food and Drug Administration. The NUsurface® Meniscus Implant is the first “artificial meniscus” to be marketed in Europe and, if cleared by the FDA, would be the first ...
-
IlluminOss Medical Receives FDA Clearance for Expanded Clinical Use for Pelvic, Clavicle and Small-Bone Fractures
IlluminOss Medical, a medical device company focused on minimally invasive orthopedic fracture repair, today announced that it has received expanded U.S. Food and Drug Administration (FDA 510k) clearance for its Photodynamic Bone Stabilization System for treatment of fractures of the pelvis, clavicle, and the small bones of the hands and feet: metacarpals, metatarsals, and phalanges. The ...
-
Final Patient Treated in Clinical Trials for Active Implants’ NUsurface Meniscus Implant
Active Implants LLC, a company that develops orthopedic implant solutions, today announced that the final patient was treated in the two clinical trials evaluating the NUsurface Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorated meniscus tissue. The trials are being conducted to evaluate the safety and effectiveness of the NUsurface Meniscus Implant in ...
-
Imperial Innovations Launches Orthonika
Imperial Innovations is pleased to announce the launch of Orthonika, a spinout company from Imperial College London that is developing a novel knee meniscus replacement, MenisciKnit™. Orthonika is a collaboration with Sierra MedTech, a specialist in the design and fabrication of engineered substrates for use in medicine. Orthonika has been launched through Co.Create, the company formation ...
By Orthonika
-
Active Implants’ NUsurface Meniscus Implant Provides Statistically Superior Pain Relief
Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced two-year results of the MERCURY study, which showed that the company’s NUsurface® Meniscus Implant provides statistically superior pain relief beginning at six months compared to non-surgical therapy. The results were presented at the American Orthopedic Society for Sports ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you